Model
Edge
BioMarin Pharmaceutical Inc
BMRN
Filing Type
8-K
Filing Date
4/26/2026
Updated
4/27/26, 6:50 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
EX-4.1
EX-4.1
EX-10.1
EX-10.1
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
GRAPHIC
Graphic